Anzeige
Mehr »
Login
Sonntag, 26.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40S1T | ISIN: CA81688C3003 | Ticker-Symbol:
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
SENDERO RESOURCES CORP Chart 1 Jahr
5-Tage-Chart
SENDERO RESOURCES CORP 5-Tage-Chart
ACCESS Newswire
278 Leser
Artikel bewerten:
(1)

Sendero Resources: Early Warning Disclosure

Finanznachrichten News

VANCOUVER, BC / ACCESS Newswire / January 24, 2025 / Sendero Resources Corp. (TSXV:SEND) (the "Company" or "Sendero") announces that as a result of the closing of a private placement (the "Private Placement") as previously announced on December 24, 2024 and December 30, 2024, two persons are required to announce their shareholdings in accordance with National Instrument 62-103 The Early Warning System and Related Take Over Bids and Insider Reporting Issues (NI 62-103). The Private Placement consisted of Units, each Unit consisting of one common share (each a "Share") and one common share purchase warrant (each a "Warrant").

1. Peter Marrone:

  1. he has SEDAR filed an early warning report in connection with his holdings of securities in the capital of the Company on today's date. A copy can be found under the Company's profile on www.sedarplus.ca;

  2. he acquired beneficial ownership and control over 1,666,666 shares and 1,666,666 Warrants of the Company;

  3. he acted independently, and there are no joint actors associated with him;

  4. no securities of the Company were previously held; and

  5. he beneficially owns and controls, an aggregate of 1,666,666 Shares and 1,666,666 Warrants representing approximately 8.47% of the Issuer's issued and outstanding on an undiluted basis and approximately 15.61% on a partially diluted basis.

2. Jeremy Gillis advises that pursuant to NI 62-103:

  1. he has SEDAR filed an early warning report in connection with his holdings of securities in the capital of the Company on today's date. A copy can be found under the Company's profile on www.sedarplus.ca;

  2. he acquired beneficial ownership and control over 1,500,000 Shares and 1,500,000 Warrants of the Company;

  3. 1302580 B.C. Ltd. acted as a joint actor in association with his acquisition;

  4. he previously owned or controlled 189,276 Shares of the Company; and

  5. he beneficially owns and controls, an aggregate of 1,689,276 Common Shares and 1,500,000 Common Share purchase warrants representing approximately 8.58% of the Company's issued and outstanding on an undiluted basis and approximately 15.05% on a partially diluted basis.

Either of the above persons ("Investors") may acquire additional securities of the Company, or may sell some or all of the securities now held by them from time to time in the future, but neither has present intentions in either regard. While the Investors do not presently have any plans or intentions to do any of the following, they will be working with the Company to seek new business opportunities, and as such may (a) undertake a corporate transaction, such as a merger, reorganization or liquidation, involving the Company or any of its subsidiaries; (b) sell or transfer any other material assets to the Company; or cause the Company to sell or dispose of any of its material assets; (c) change the board of directors or management of the Company, including changing the number or term of directors or to fill any existing vacancy on its board; (d) effect a material change in the present capitalization or dividend policy of the Company; (e) effect a material change in the Company's business or corporate structure; (f) effect a change in the Company's charter, bylaws or similar instruments or another action which might impede the acquisition of control of the Company by any person or company; (g) cause the Company to cease to be a reporting issuer in any jurisdiction of Canada; (h) solicit proxies from securityholders; or (i) any action similar to any of those enumerated above.

Further Information
For further information, please contact:
Sendero Resources Corp,
Alex Gostevskikh Chief Executive Officer

+1 888 455 7620
Email:info@senderoresources.com

SOURCE: Sendero Resources



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.